A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease

NCT02453061 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Huntington Disease

Interventions

DRUG: Triheptanoin oil
DRUG: Placebo

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Collaborators

[object Object]